These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 25981932)

  • 21. Metformin inhibits growth of eutopic stromal cells from adenomyotic endometrium via AMPK activation and subsequent inhibition of AKT phosphorylation: a possible role in the treatment of adenomyosis.
    Xue J; Zhang H; Liu W; Liu M; Shi M; Wen Z; Li C
    Reproduction; 2013 Oct; 146(4):397-406. PubMed ID: 23904524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Blockade of reactive oxygen species and Akt activation is critical for anti-inflammation and growth inhibition of metformin in phosphatase and tensin homolog-deficient RAW264.7 cells.
    Lin CF; Young KC; Bai CH; Yu BC; Ma CT; Chien YC; Su HC; Wang HY; Liao CS; Lai HW; Tsao CW
    Immunopharmacol Immunotoxicol; 2013 Dec; 35(6):669-77. PubMed ID: 24053326
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metformin enhances anti-tumor effect of L-type amino acid transporter 1 (LAT1) inhibitor.
    Ueno S; Kimura T; Yamaga T; Kawada A; Ochiai T; Endou H; Sakurai H
    J Pharmacol Sci; 2016 Jun; 131(2):110-7. PubMed ID: 27262901
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metformin promotes irisin release from murine skeletal muscle independently of AMP-activated protein kinase activation.
    Li DJ; Huang F; Lu WJ; Jiang GJ; Deng YP; Shen FM
    Acta Physiol (Oxf); 2015 Mar; 213(3):711-21. PubMed ID: 25382002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of AMP-activated protein kinase reduces hyperglycemia-induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells.
    Kukidome D; Nishikawa T; Sonoda K; Imoto K; Fujisawa K; Yano M; Motoshima H; Taguchi T; Matsumura T; Araki E
    Diabetes; 2006 Jan; 55(1):120-7. PubMed ID: 16380484
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metformin synergistically enhances antitumor activity of histone deacetylase inhibitor trichostatin a against osteosarcoma cell line.
    Duo J; Ma Y; Wang G; Han X; Zhang C
    DNA Cell Biol; 2013 Apr; 32(4):156-64. PubMed ID: 23451817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metformin sensitizes human bladder cancer cells to TRAIL-induced apoptosis through mTOR/S6K1-mediated downregulation of c-FLIP.
    Zhang T; Wang X; He D; Jin X; Guo P
    Anticancer Drugs; 2014 Sep; 25(8):887-97. PubMed ID: 24714080
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metformin suppresses glucose-6-phosphatase expression by a complex I inhibition and AMPK activation-independent mechanism.
    Ota S; Horigome K; Ishii T; Nakai M; Hayashi K; Kawamura T; Kishino A; Taiji M; Kimura T
    Biochem Biophys Res Commun; 2009 Oct; 388(2):311-6. PubMed ID: 19664596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metformin transiently inhibits colorectal cancer cell proliferation as a result of either AMPK activation or increased ROS production.
    Mogavero A; Maiorana MV; Zanutto S; Varinelli L; Bozzi F; Belfiore A; Volpi CC; Gloghini A; Pierotti MA; Gariboldi M
    Sci Rep; 2017 Nov; 7(1):15992. PubMed ID: 29167573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metformin inhibits the proliferation of canine mammary gland tumor cells through the AMPK/AKT/mTOR signaling pathway
    Fan Y; Ren X; Wang Y; Xu E; Wang S; Ge R; Liu Y
    Oncol Lett; 2021 Dec; 22(6):852. PubMed ID: 34733370
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Caffeic Acid Expands Anti-Tumor Effect of Metformin in Human Metastatic Cervical Carcinoma HTB-34 Cells: Implications of AMPK Activation and Impairment of Fatty Acids De Novo Biosynthesis.
    Tyszka-Czochara M; Konieczny P; Majka M
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28230778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic significance of AMPK activation and therapeutic effects of metformin in hepatocellular carcinoma.
    Zheng L; Yang W; Wu F; Wang C; Yu L; Tang L; Qiu B; Li Y; Guo L; Wu M; Feng G; Zou D; Wang H
    Clin Cancer Res; 2013 Oct; 19(19):5372-80. PubMed ID: 23942093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Combination of Sorafenib and Everolimus Abrogates mTORC1 and mTORC2 upregulation in osteosarcoma preclinical models.
    Pignochino Y; Dell'Aglio C; Basiricò M; Capozzi F; Soster M; Marchiò S; Bruno S; Gammaitoni L; Sangiolo D; Torchiaro E; D'Ambrosio L; Fagioli F; Ferrari S; Alberghini M; Picci P; Aglietta M; Grignani G
    Clin Cancer Res; 2013 Apr; 19(8):2117-31. PubMed ID: 23434734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AMPK inhibits MTDH expression via GSK3β and SIRT1 activation: potential role in triple negative breast cancer cell proliferation.
    Gollavilli PN; Kanugula AK; Koyyada R; Karnewar S; Neeli PK; Kotamraju S
    FEBS J; 2015 Oct; 282(20):3971-85. PubMed ID: 26236947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metformin reduces cisplatin-mediated apoptotic death of cancer cells through AMPK-independent activation of Akt.
    Janjetovic K; Vucicevic L; Misirkic M; Vilimanovich U; Tovilovic G; Zogovic N; Nikolic Z; Jovanovic S; Bumbasirevic V; Trajkovic V; Harhaji-Trajkovic L
    Eur J Pharmacol; 2011 Jan; 651(1-3):41-50. PubMed ID: 21114978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in p53 status significantly influence the cellular response and cell survival to 1,25-dihydroxyvitamin D3-metformin cotreatment in colorectal cancer cells.
    Abu El Maaty MA; Strassburger W; Qaiser T; Dabiri Y; Wölfl S
    Mol Carcinog; 2017 Nov; 56(11):2486-2498. PubMed ID: 28618116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metformin protects endothelial function in diet-induced obese mice by inhibition of endoplasmic reticulum stress through 5' adenosine monophosphate-activated protein kinase-peroxisome proliferator-activated receptor δ pathway.
    Cheang WS; Tian XY; Wong WT; Lau CW; Lee SS; Chen ZY; Yao X; Wang N; Huang Y
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):830-6. PubMed ID: 24482374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metformin and Breast Cancer: Molecular Targets.
    Faria J; Negalha G; Azevedo A; Martel F
    J Mammary Gland Biol Neoplasia; 2019 Jun; 24(2):111-123. PubMed ID: 30903363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of Pancreatic β Cell Mass by Cross-Interaction between CCAAT Enhancer Binding Protein β Induced by Endoplasmic Reticulum Stress and AMP-Activated Protein Kinase Activity.
    Matsuda T; Takahashi H; Mieda Y; Shimizu S; Kawamoto T; Matsuura Y; Takai T; Suzuki E; Kanno A; Koyanagi-Kimura M; Asahara S; Bartolome A; Yokoi N; Inoue H; Ogawa W; Seino S; Kido Y
    PLoS One; 2015; 10(6):e0130757. PubMed ID: 26091000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level.
    Ben Sahra I; Laurent K; Loubat A; Giorgetti-Peraldi S; Colosetti P; Auberger P; Tanti JF; Le Marchand-Brustel Y; Bost F
    Oncogene; 2008 Jun; 27(25):3576-86. PubMed ID: 18212742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.